PCR
News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.
Co-Diagnostics Posts Q1 Revenue Boost on SARS-CoV-2 Test Sales
The company posted a first quarter net profit of $7.9 million, or $.26 per share, compared with a year-ago net loss of $1.1 million, or $.05 per share.
Lucira Health Posts $4.5M in Sales in First Quarter as Publicly Traded Firm
The firm had a net loss of $13.3 million, or $.58 per share, in Q1 2021 compared to a net loss of $1.7 million, or $.76 per share, a year ago.
Becton Dickinson Gets CE Mark for At-Home Self-Collected HPV Test Indication
The BD Onclarity test can now be used with samples collected at home on the firm's BD Viper and BD Cor molecular diagnostic systems.
CARB-X Awards SpeeDx up to $3.7 Million for CT/NG Test on QuantumDx Q-POC
SpeeDx will develop a rapid, portable test for chlamydia and gonorrhea that can determine the latter's antimicrobial susceptibility, as well.
Applied DNA Sciences Subsidiary Gets CLIA Certification From NY State Department of Health
The company said it can now perform high-throughput SARS-CoV-2 testing with assays that have received Emergency Use Authorization from the FDA.